药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Codeine-N-oxide
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Dexverapamil.
Codeine-N-oxide
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Dexverapamil.
Codeine-N-oxide
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Dexverapamil.
Codeine-N-oxide
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Dexverapamil.
Codeine-N-oxide
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Dexverapamil.
Codeine-N-oxide
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Dexverapamil.
Codeine-N-oxide
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Dexverapamil.
Codeine-N-oxide
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Dexverapamil.
Codeine-N-oxide
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dexverapamil.
Codeine-N-oxide
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Dexverapamil.
Codeine-N-oxide
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Dexverapamil.
Codeine-N-oxide
Berotralstat
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Berotralstat.
Codeine-N-oxide
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Dexverapamil.
Codeine-N-oxide
Ivosidenib
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Ivosidenib.
Codeine-N-oxide
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Dexverapamil.
Codeine-N-oxide
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Dexverapamil.
Codeine-N-oxide
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Dexverapamil.
Codeine-N-oxide
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Dexverapamil.
Codeine-N-oxide
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Dexverapamil.
Codeine-N-oxide
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Dexverapamil.